Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-08

FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approved a supplemental application for cetirizine hydrochloride from PAI Holdings, LLC dba PAI Pharma. This action approves a supplemental change to an alr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine hydrochloride (Cetirizine hydrochloride)

Snippet

SUPPL AP for CETIRIZINE HYDROCHLORIDE (CETIRIZINE HYDROCHLORIDE)